1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-propyn-1-ol | 460079-62-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-propyn-1-ol
• 英文别名: 1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]prop-2-yn-1-ol
• CAS: 460079-62-3
• 化学式: C₁₇H₁₃ClN₂O
• 分子量: 296.756
• InChiKey: ZMIVEMFEXHYIPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  37.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-propyn-1-ol 在 manganese dioxide hexanes 、 乙酸乙酯 作用下， 以 氯仿 为溶剂， 反应 18.0h， 以1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-propyn-1-one (4.57 g, 41%) was obtained as a pale yellow crystalline的产率得到1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-propyn-1-one
  参考文献：
  名称：

  Therapeutic Compounds

  摘要：

  本发明提供了式(I)的化合物；包含相同化合物的药物组合物，制备相同化合物的方法以及它们作为药物剂量的使用。

  公开号：

  US20060293344A1
• 作为产物：
  描述：

  2-甲基-6-氯吡啶 在 sodium hydroxide 、 盐酸羟胺 、 三乙胺 、 三氟乙酸酐 、 lithium hexamethyldisilazane 、 三氯氧磷 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 水 为溶剂， 反应 8.0h， 生成 1-[7-chloro-2-(3-methylphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-propyn-1-ol
  参考文献：
  名称：

  Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses

  摘要：

  Herpesviruses are a significant source of human disease; amongst these herpes simplex virus 1 (HSV-1) and HSV-2 are very prevalent and cause recurrent infections. We recently identified a pyrazolo[1,5-a]pyridine scaffold that showed promising activity against HSV-1 and HSV-2 in Vero cell antiviral assays. Here, we describe the synthesis and anti-herpetic activity of several 3-pyrimidinyl-2-phenylpyrazolo[1,5-a]pyridines with differing 2-phenyl substitution patterns. Approaches to rapidly access a number of analogs with different 2-phenyl substitution patterns are outlined. Several of the compounds described have comparable activity to acyclovir against HSV-1 and HSV-2. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.05.043

文献信息

• Therapeutic compounds
  申请人：Boyd Leslie F.

  公开号：US20050049260A1

  公开（公告）日：2005-03-03

  The present invention provides compounds of formula (I): pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

  本发明提供了公式（I）的化合物：包含它们的药物组合物，制备它们的过程以及它们作为药物代理的用途。
• Pyrazolopyridinyl pyrimidine therapeutic compounds
  申请人：SmithKline Beecham Corporation

  公开号：US07153855B2

  公开（公告）日：2006-12-26

  The present invention provides compounds of formula (I): pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

  本发明提供了公式(I)的化合物：包含它们的药物组合物，制备它们的方法以及它们作为药物剂的应用。
• Therapeutic Compounds
  申请人：Boyd Leslie F.

  公开号：US20060293344A1

  公开（公告）日：2006-12-28

  The present invention provides compounds of formula (I); pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

  本发明提供了式(I)的化合物；包含相同化合物的药物组合物，制备相同化合物的方法以及它们作为药物剂量的使用。
• US7153855B2
  申请人：——

  公开号：US7153855B2

  公开（公告）日：2006-12-26
• Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses
  作者：Kristjan S. Gudmundsson、Brian A. Johns、Zhicheng Wang、Elizabeth M. Turner、Scott H. Allen、George A. Freeman、F. Leslie Boyd、Connie J. Sexton、Dean W. Selleseth、Kelly R. Moniri、Katrina L. Creech

  DOI：10.1016/j.bmc.2005.05.043

  日期：2005.9

  Herpesviruses are a significant source of human disease; amongst these herpes simplex virus 1 (HSV-1) and HSV-2 are very prevalent and cause recurrent infections. We recently identified a pyrazolo[1,5-a]pyridine scaffold that showed promising activity against HSV-1 and HSV-2 in Vero cell antiviral assays. Here, we describe the synthesis and anti-herpetic activity of several 3-pyrimidinyl-2-phenylpyrazolo[1,5-a]pyridines with differing 2-phenyl substitution patterns. Approaches to rapidly access a number of analogs with different 2-phenyl substitution patterns are outlined. Several of the compounds described have comparable activity to acyclovir against HSV-1 and HSV-2. (c) 2005 Elsevier Ltd. All rights reserved.